Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Hematology

Why is Spleen Removal Needed for Beta-Thalassemia?

At a Glance

Spleen removal (splenectomy) is sometimes needed in beta-thalassemia major when the spleen becomes massively enlarged and overactive. An overactive spleen traps and destroys healthy transfused red blood cells, which drastically increases the patient's need for frequent blood transfusions.

In this answer

3 sections

01

Why the Spleen Becomes Enlarged

02

When is a Splenectomy Recommended?

03

Life After Spleen Removal: Risks and Precautions

You or your child will not necessarily need a spleen removal. In the past, removing the spleen (a splenectomy) was a nearly universal part of managing beta-thalassemia major. Today, however, consistent and modern transfusion therapies help prevent the spleen from becoming enlarged in the first place, making the surgery much less common [1][2][3]. When a splenectomy is recommended today, it is usually because the spleen has grown too large and is destroying red blood cells faster than they can be replaced by transfusions [4][5].

Why the Spleen Becomes Enlarged

To understand why the spleen sometimes needs to be removed, it helps to know what it actually does. The spleen is an organ located in the upper left side of your abdomen that acts as the body’s blood filter, removing old or damaged red blood cells. In beta-thalassemia major, the body produces abnormal, fragile red blood cells.

This causes the spleen to enlarge (a condition called splenomegaly) for two main reasons:

  • Overwork: The spleen works constantly to filter out the high number of abnormal red blood cells. Just like a muscle that lifts weights, this constant heavy workload causes the spleen to grow larger [6][7][8].
  • Emergency Blood Production: Because the bone marrow struggles to make enough healthy red blood cells, the spleen tries to help by producing blood cells itself—a process called extramedullary hematopoiesis [6][7][9].

When the spleen becomes massively enlarged, it can become overactive—a state known as hypersplenism [2][6]. An overactive spleen becomes too aggressive, trapping and destroying not only your own fragile blood cells but also the healthy red blood cells provided during a blood transfusion [4][5].

A splenectomy is not done routinely; it is a major decision made carefully by your care team. Doctors typically only recommend removing the spleen when the risks of keeping it outweigh the risks of surgery. The primary criteria include:

  • Drastically Increased Transfusion Needs: If the spleen is destroying transfused blood, you or your child will need transfusions much more frequently to maintain safe hemoglobin levels [4][5][10]. If the annual amount of blood needed jumps significantly, a splenectomy can help reduce the transfusion burden [10][4].
  • Low Platelets or White Blood Cells: An overactive spleen may also start destroying platelets (which help blood clot) or white blood cells (which fight infection). Dropping white blood cells can make you highly susceptible to routine infections, making surgery necessary [2][6].
  • Physical Discomfort: A massively enlarged spleen can press against the stomach, causing pain in the upper left abdomen or making it difficult to eat a full meal.

If surgery is required, it is often done laparoscopically (through small keyhole incisions) to speed up recovery, though a traditional open surgery may be needed if the spleen is exceptionally large [11][12]. Additionally, because patients with beta-thalassemia frequently develop gallstones, surgeons will often remove the gallbladder (a procedure called a cholecystectomy) at the same time if stones are present. Some centers may also discuss a partial splenectomy (removing only part of the spleen) to help preserve some immune function [13][14].

Life After Spleen Removal: Risks and Precautions

While removing the spleen can successfully lower the need for frequent blood transfusions, it does not cure beta-thalassemia, and you will still require lifelong transfusions and iron chelation therapy [10][4].

Furthermore, living without a spleen introduces two major lifelong health risks:

1. Severe Infections

The most significant long-term risk after a splenectomy is an increased vulnerability to severe, fast-acting bacterial infections (known as Overwhelming Post-Splenectomy Infection or OPSI) [15][16][17]. The spleen plays a vital role in fighting “encapsulated” bacteria like Streptococcus pneumoniae [15][18]. Because children are especially vulnerable [15][19], strict protective protocols are required:

  • Intensive Vaccination: Patients must receive a full series of specific vaccines (such as pneumococcal, meningococcal, and Haemophilus influenzae) prior to the surgery [20][17][18].
  • Daily Prophylactic Antibiotics: Most children and adults without a spleen must take daily preventative antibiotics (often penicillin) for many years, and sometimes for life, to prevent infections before they start [20][17][21].
  • Emergency Action: Any fever (typically 100.4°F / 38.0°C or higher) after a splenectomy is treated as a medical emergency requiring immediate evaluation and strong intravenous (IV) antibiotics [22][23][24]. The risk of serious infection persists for the rest of your life, requiring constant vigilance [25][26].

2. Increased Risk of Blood Clots and Lung Complications

Patients who have had their spleen removed are at a persistently higher risk for cardiovascular issues and blood clots, such as deep vein thrombosis (DVT), pulmonary embolism, and pulmonary hypertension (high blood pressure in the lungs) [10][27][28]. Your care team will monitor for these complications closely, often using routine echocardiograms to screen the heart and lungs [29].

The best defense for your spleen is sticking closely to the prescribed transfusion and chelation schedule, as proper early management greatly reduces the likelihood that the spleen will become enlarged in the first place [1][2][3].

Common questions in this guide

Why does the spleen get so large in beta-thalassemia major?
The spleen enlarges because it works constantly to filter out fragile, abnormal red blood cells produced by the disease. It may also grow because it attempts to produce new blood cells to help the struggling bone marrow.
When is a splenectomy recommended for thalassemia?
Doctors typically recommend removing the spleen when it becomes overactive and destroys transfused blood cells, dramatically increasing your transfusion needs. It may also be recommended if the spleen destroys white blood cells, platelets, or causes severe physical discomfort.
What are the long-term risks of living without a spleen?
The most significant long-term risks are a high vulnerability to severe bacterial infections and an increased risk of blood clots and pulmonary hypertension. Patients require lifelong medical monitoring and precautions to manage these risks safely.
How do you prevent infections after a spleen removal?
To prevent life-threatening infections, patients must receive a full series of specific vaccines before the surgery. After surgery, most patients must take daily preventative antibiotics for many years, and any fever must be treated as a medical emergency.
Does removing the spleen cure beta-thalassemia major?
No, removing the spleen does not cure beta-thalassemia major. Patients will still require ongoing, lifelong blood transfusions and regular iron chelation therapy after the surgery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.At what volume of annual blood transfusions would you consider my or my child's needs to be 'drastically increasing'?
  2. 2.How often do you measure the size of the spleen, and are there signs of enlargement right now?
  3. 3.Will you check my or my child's gallbladder for stones to see if it needs to be removed during the same surgery?
  4. 4.If a splenectomy becomes necessary, what is your protocol for pre-surgery vaccines and post-surgery antibiotics?
  5. 5.Are there spleen-preserving surgical options, like partial splenectomy, that might be appropriate for our situation?
  6. 6.What specific signs of hypersplenism (like dropping white blood cell or platelet counts) should we be watching for in regular blood work?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

New Meds to Reduce Beta-Thalassemia Transfusions?Does Beta-Thalassemia Major Affect Growth & Puberty?Does Beta-Thalassemia Gene Therapy Cause Infertility?Why Does Beta-Thalassemia Cause Bone & Facial Changes?How Do Zynteglo & Casgevy Work for Beta-Thalassemia?How to Manage Teen Beta-Thalassemia Treatment BurnoutChances of Beta-Thalassemia Major for Carrier ParentsWhat Happens If You Miss Iron Chelation Doses?What Is a Cardiac T2* MRI for Thalassemia?How Much Do Zynteglo and Casgevy Gene Therapies Cost?What Is the Life Expectancy for Beta-Thalassemia Major?What is the Pesaro Score for Stem Cell Transplants?Why Do You Need Vision & Hearing Exams With Chelation?Why Do Beta-Thalassemia Symptoms Start at 3-6 Months?

References

References (29)
  1. 1

    Challenges in chronic transfusion for patients with thalassemia.

    Lal A

    Hematology. American Society of Hematology. Education Program 2020; (2020(1)):160-166 doi:10.1182/hematology.2020000102.

    PMID: 33275743
  2. 2

    Achievement of Pre- and Post-Transfusion Hemoglobin Levels in Adult Transfusion-Dependent Beta Thalassemia: Associated Factors and Relationship to Reduction of Spleen Enlargement.

    Atmakusuma TD, Saragih EYP, Rajabto W

    International journal of general medicine 2021; (14()):7515-7521 doi:10.2147/IJGM.S338114.

    PMID: 34754224
  3. 3

    Thalassemia.

    Merkeley H, Bolster L

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2020; (192(41)):E1210 doi:10.1503/cmaj.191613.

    PMID: 33051316
  4. 4

    Post Splenectomy Outcome in β-Thalassemia.

    Merchant RH, Shah AR, Ahmad J, et al.

    Indian journal of pediatrics 2015; (82(12)):1097-100 doi:10.1007/s12098-015-1792-5.

    PMID: 26099360
  5. 5

    Long-term Results of Splenectomy in Transfusion-dependent Thalassemia.

    Akca T, Ozdemir GN, Aycicek A, Ozkaya G

    Journal of pediatric hematology/oncology 2023; (45(3)):143-148 doi:10.1097/MPH.0000000000002468.

    PMID: 35446800
  6. 6

    An Unusual Presentation of a Patient with Leg Ulcers: A Case Report.

    Zafar S, Saleem K, Rashid A

    Cureus 2019; (11(12)):e6293 doi:10.7759/cureus.6293.

    PMID: 31938587
  7. 7

    Low back pain in beta thalassemia major revealing sacral extramedullay hematopoeisis: A case report.

    Ahmad RW, Okar LA, Elhiday A, et al.

    Clinical case reports 2021; (9(5)):e04258 doi:10.1002/ccr3.4258.

    PMID: 34084519
  8. 8

    A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?

    Cappellini MD, Porter JB, Viprakasit V, Taher AT

    Blood reviews 2018; (32(4)):300-311 doi:10.1016/j.blre.2018.02.001.

    PMID: 29455932
  9. 9

    Spinal cord compression due to extramedullary hematopoiesis in patient with Beta thalassemia major.

    Subahi EA, Abdelrazek M, Yassin MA

    Clinical case reports 2021; (9(1)):405-409 doi:10.1002/ccr3.3542.

    PMID: 33489190
  10. 10

    Cardiovascular Effects of Splenomegaly and Splenectomy in Beta-Thalassemia Major.

    Abbas S, Khan HA, Rehman W, et al.

    Cureus 2024; (16(11)):e74186 doi:10.7759/cureus.74186.

    PMID: 39712674
  11. 11

    Laparoscopic Subtotal Splenectomy in Pediatric Patients With Hematologic Disorders: A Case Series and Operative Technique.

    Yamoto M, Sugai Y, Nemoto Y, et al.

    Asian journal of endoscopic surgery 2025; (18(1)):e70146 doi:10.1111/ases.70146.

    PMID: 40915637
  12. 12

    Symptomatic Recurrent Splenomegaly Following Partial Splenectomy in Patients With Hereditary Spherocytosis.

    Abdelhafeez AH, Rosenberger K, Crest P, et al.

    Pediatric blood & cancer 2026; e70249 doi:10.1002/1545-5017.70249.

    PMID: 41852320
  13. 13

    Role of Partial Splenectomy in Gaucher's Disease in Resource Challenged Nations.

    Santanakrishnan R, Dasaratha V, Munianjanappa NB, et al.

    Journal of Indian Association of Pediatric Surgeons 2023; (28(2)):149-153 doi:10.4103/jiaps.jiaps_132_22.

    PMID: 37197236
  14. 14

    Splenic hamartomas in children.

    Milickovic M, Rasic P, Cvejic S, et al.

    World journal of clinical cases 2024; (12(11)):1909-1917 doi:10.12998/wjcc.v12.i11.1909.

    PMID: 38660549
  15. 15

    Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study.

    Theilacker C, Ludewig K, Serr A, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; (62(7)):871-878 doi:10.1093/cid/civ1195.

    PMID: 26703862
  16. 16

    Infectious purpura fulminans associated with pneumococcal septicaemia in a patient with unacknowledged functional asplenia.

    Duus S, Jespersen S, Wejse C

    BMJ case reports 2024; (17(3)) doi:10.1136/bcr-2022-251397.

    PMID: 38531552
  17. 17

    Updated Recommendations on the Prevention and Treatment of Infections in Children With Asplenia/Hyposplenism.

    Guri A, Ben-Ami T

    Journal of pediatric hematology/oncology 2024; (46(5)):225-232 doi:10.1097/MPH.0000000000002855.

    PMID: 38691084
  18. 18

    Active offer of vaccinations during hospitalization improves coverage among splenectomized patients: An Italian experience.

    Gallone MS, Martino C, Quarto M, et al.

    American journal of infection control 2017; (45(8)):e87-e89 doi:10.1016/j.ajic.2017.02.039.

    PMID: 28410825
  19. 19

    Preventing infections in children and adults with asplenia.

    Lee GM

    Hematology. American Society of Hematology. Education Program 2020; (2020(1)):328-335 doi:10.1182/hematology.2020000117.

    PMID: 33275684
  20. 20

    Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand.

    Kanhutu K, Jones P, Cheng AC, et al.

    Internal medicine journal 2017; (47(8)):848-855 doi:10.1111/imj.13348.

    PMID: 27925427
  21. 21

    Post-splenectomy sepsis: preventative strategies, challenges, and solutions.

    Luu S, Spelman D, Woolley IJ

    Infection and drug resistance 2019; (12()):2839-2851 doi:10.2147/IDR.S179902.

    PMID: 31571940
  22. 22

    Complications in the adult asplenic patient: A review for the emergency clinician.

    Long B, Koyfman A, Gottlieb M

    The American journal of emergency medicine 2021; (44()):452-457 doi:10.1016/j.ajem.2020.03.049.

    PMID: 32247651
  23. 23

    Post-splenectomy Sepsis: A Review of the Literature.

    Tahir F, Ahmed J, Malik F

    Cureus 2020; (12(2)):e6898 doi:10.7759/cureus.6898.

    PMID: 32195065
  24. 24

    Medical complications following splenectomy.

    Buzelé R, Barbier L, Sauvanet A, Fantin B

    Journal of visceral surgery 2016; (153(4)):277-86.

    PMID: 27289254
  25. 25

    Incidence and risk factors for sepsis after childhood splenectomy.

    Madenci AL, Armstrong LB, Kwon NK, et al.

    Journal of pediatric surgery 2019; (54(7)):1445-1448 doi:10.1016/j.jpedsurg.2018.06.024.

    PMID: 30029846
  26. 26

    Burden of COVID-19 disease and vaccine coverages in Apulian splenectomized patients: A retrospective observational study.

    Bianchi FP, Stefanizzi P, Rizzi D, et al.

    British journal of haematology 2023; (201(6)):1072-1080 doi:10.1111/bjh.18731.

    PMID: 36942786
  27. 27

    A 34-Year-Old Man With Bilateral Paraspinal Masses and Shortness of Breath.

    White K, Blay C, Ataya A, et al.

    Chest 2019; (156(5)):e99-e102 doi:10.1016/j.chest.2019.05.043.

    PMID: 31699236
  28. 28

    Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq.

    Mohammad AM, Dawad MM, Kashmoola MA, Al-Allawi N

    PloS one 2020; (15(12)):e0243648 doi:10.1371/journal.pone.0243648.

    PMID: 33301537
  29. 29

    A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major.

    Amoozgar H, Zeighami S, Haghpanah S, Karimi M

    Hematology (Amsterdam, Netherlands) 2017; (22(1)):25-29 doi:10.1080/10245332.2016.1226699.

    PMID: 27650671

This page provides educational information about spleen removal for beta-thalassemia major and does not constitute medical advice. Always discuss surgical options, transfusion needs, and infection risks with your hematology care team.

Get notified when new evidence is published on Beta-thalassemia major.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.